Saturday 17 October 2026
Export DRTS’s income statement to Excel — free account
Alpha Tau Medical Ltd.
DRTS Healthcare Biotechnology
In the quarter to June 2026, EPS fell 100.0%, free cash flow fell 30.4% and total debt rose 12.8%, each against the same quarter a year earlier.
12.29
0.87
−6.61%
Follow DRTS
| Dec '19 | Jan '20 | Dec '20 | Jan '21 | Dec '21 | Jan '22 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
— | 22.73 | 22.73 | 7.41 | 7.41 | 24.55 | 24.55 | 12.07 | 7.40 | 7.45 |
Net Debt/EBITDA |
0.00 | 0.00 | 5.09 | 0.00 | 2.45 | 0.00 | 3.38 | 2.20 | 1.55 | 1.63 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.22% | 6.45% | 6.01% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.09 | 0.08 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.83 | 0.82 | 0.82 | 0.43 | 0.43 | 0.71 | 0.71 | 0.62 | 0.62 | 0.63 |
Capex/Depreciation |
(19.59) | 0.00 | (43.80) | 0.00 | (3.77) | 0.00 | (0.92) | (5.96) | (2.03) | (4.93) |
Interest Coverage |
(26.01) | 0.00 | 17.78 | (130.71) | (1.02) | (35.91) | (20.01) | 5.46 | 8.39 | (193.98) |
| 0.00% | 0.00% | 105.37% | 0.00% | 126.24% | 0.00% | (95.27%) | (30.67%) | (43.16%) | (61.00%) | |
| 0.00% | 0.00% | (16.76%) | 0.00% | (57.29%) | 0.00% | (41.59%) | (25.63%) | (32.80%) | (44.44%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (7,250.90%) | (268.77%) | (261.11%) | (255.98%) |
Return on Tangible Assets |
0.00% | (17.50%) | (17.50%) | (76.21%) | (76.21%) | (29.25%) | (30.80%) | (31.88%) | (45.69%) | (48.74%) |
Average Days of Receivables |
— | — | — | — | — | 0.00 | — | — | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | — | 0.00% | — | 0.00% | — | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(0.24) | (0.18) | (0.27) | (0.29) | (0.36) | (0.38) | (0.39) | (0.35) | (0.31) | (0.41) |
Cash per Share |
0.00 | 0.40 | 1.16 | 0.59 | 0.79 | 1.66 | 1.66 | 1.18 | 0.85 | 0.91 |
Shareholders Equity per Share |
0.00 | (0.21) | (0.21) | (0.86) | (0.86) | 1.66 | 1.66 | 1.22 | 0.90 | 0.96 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | (0.21) | (0.21) | (0.86) | (0.86) | 1.66 | 1.66 | 1.22 | 0.90 | 0.96 |
Free Cash Flow |
(8.20) | (7.25) | (11.02) | (11.81) | (14.74) | (23.88) | (24.78) | (24.36) | (22.02) | (32.76) |
Working Capital |
— | 45.37 | 45.37 | 28.24 | 28.24 | 102.14 | 102.14 | 78.65 | 55.55 | 67.79 |
Capital Expenditures |
(1.29) | (3.77) | (3.77) | (2.93) | (2.93) | (0.90) | (0.90) | (6.40) | (2.24) | (6.07) |
Net Current Asset Value |
0.00 | (13.96) | (13.96) | (44.35) | (44.35) | 91.99 | 91.99 | 62.84 | 40.69 | 49.75 |
| Other line items | ||||||||||
Quick Ratio |
— | 7.75 | 22.31 | 5.42 | 7.25 | 24.29 | 24.29 | 11.52 | 6.87 | 6.96 |
Depreciation/Fixed assets |
0.00 | 0.02 | 0.02 | 0.10 | 0.10 | 0.07 | 0.13 | 0.08 | 0.08 | 0.06 |
Cash ROIC |
0.00% | 0.00% | (28.87%) | 0.00% | 518.43% | 0.00% | (11.74%) | (14.17%) | (17.23%) | (20.92%) |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | 0.00 | — | 0.00 | — | 0.00 | — | — | — | — |
Average Days of Payables |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | 0.00 | — | 0.00 | — | 0.00 | — | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.20) | (0.18) | (0.18) | (0.29) | (0.29) | (0.38) | (0.38) | (0.26) | (0.28) | (0.33) |
Capex per Share |
(0.04) | 0.00 | (0.09) | 0.00 | (0.07) | 0.00 | (0.01) | (0.09) | (0.03) | (0.08) |
Average Payables |
— | — | 0.96 | 1.08 | 1.08 | 1.31 | 1.31 | 1.99 | 3.05 | 3.70 |
Average Assets |
0.00 | 26.49 | 52.99 | 47.60 | 47.60 | 81.18 | 81.18 | 113.77 | 96.80 | 95.93 |
Average Common Equity |
— | (4.20) | (8.43) | (21.60) | (21.60) | 35.44 | 35.44 | 95.07 | 73.57 | 69.88 |
Capex to Sales |
0.00 | — | 0.00 | — | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates